Knome to sequence 20 genomes this year

Knome, the brainchild of renowned Harvard geneticist George Church, is reportedly on track to sequence the genomes of 20 people this year. Knome garnered worldwide attention for its plans to offer full sequencing information on individuals at a price of $350,000. A slate of start-ups including 23andMe and Navigenics have popped up to offer much more limited genetic analysis to consumers interested in finding out more about the risks they face for certain diseases.

"People assume it's hypochondriacs coming to us," Knome CEO Jorge Conde tells the Boston Globe. "It isn't. It's people who are technophiles and inherently curious about themselves, and about science."

- read the article from the Boston Globe

Suggested Articles

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.